Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
BIOCRYST PHARMACEUTICALS INC
| Metric | BIOCRYST PHARMACEUTICALS INC BCRXHealthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $875M |
| Net income (latest) | $264M |
| Operating margin | 39.0% |
| Net margin | 30.2% |
| Return on equity | −221.4% |
| Return on assets | 51.3% |
| Return on capital (ROCE) | 107.2% |
| Debt / equity | — |
| Revenue growth (YoY) | 94.1% |
| Altman Z″ (distress) | -2.63 |
| Accruals / assets | −16.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.